Christian Thomsen 1 , Dorothea Theilig 2 , Dominik Herzog 1 , Alexander Poellinger 2 , Felix Doellinger 2 , Nils Schreiter 3 , Vera Schreiter 2 , Dirk Schürmann 1 , Bettina Temmesfeld-Wollbrueck 1 , Stefan Hippenstiel 1 , Norbert Suttorp 1 , Ralf-Harto Hubner 1
09 June 2016
The exclusion of collateral ventilation (CV) and other factors affect the clinical success of endoscopic lung volume reduction (ELVR). However, despite its benefits, the outcome of ELVR remains difficult to predict. We investigated whether clinical success could be predicted by emphysema distribution assessed by computed tomography scan and baseline perfusion assessed by perfusion scintigraphy. Data from 57 patients with no CV in the target lobe (TL) were retrospectively analyzed after ELVR with valves. Pulmonary function tests (PFT), St George’s Respiratory Questionnaire (SGRQ), and 6-minute walk tests (6MWT) were performed on patients at baseline. The sample was grouped into high and low levels at the median of TL perfusion, ipsilateral nontarget lobe (INL) perfusion, and heterogeneity index (HI). These groups were analyzed for association with changes in outcome parameters from baseline to 3 months follow-up. Compared to baseline, patients showed significant improvements in PFT, SGRQ, and 6MWT (all P≤0.001). TL perfusion was not associated with changes in the outcome. High INL perfusion was significantly associated with increases in 6MWT ( P=0.014), and high HI was associated with increases in forced expiratory volume in 1 second (FEV 1), ( P=0.012). Likewise, there were significant correlations for INL perfusion and improvement of 6MWT ( r=0.35, P=0.03) and for HI and improvement in FEV 1 ( r=0.45, P=0.001). This study reveals new attributes that associate with positive outcomes for patient selection prior to ELVR. Patients with high perfusions in INL demonstrated greater improvements in 6MWT, while patients with high HI were more likely to respond in FEV 1.